{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T18:57:28Z","timestamp":1771873048543,"version":"3.50.1"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2008,12,23]],"date-time":"2008-12-23T00:00:00Z","timestamp":1229990400000},"content-version":"vor","delay-in-days":5835,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[1993,1,1]],"date-time":"1993-01-01T00:00:00Z","timestamp":725846400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["STEM CELLS"],"published-print":{"date-parts":[[1993,1]]},"DOI":"10.1002\/stem.5530110109","type":"journal-article","created":{"date-parts":[[2009,6,15]],"date-time":"2009-06-15T14:05:43Z","timestamp":1245074743000},"page":"49-55","source":"Crossref","is-referenced-by-count":14,"title":["Recombinant human erythropoietin (rhuepo) for treatment of myelodysplastic syndrome"],"prefix":"10.1093","volume":"11","author":[{"given":"Zella R.","family":"Zeigler","sequence":"first","affiliation":[{"name":"West Penn Hospital, Western Pennsylvania Cancer Institute, Pittsburgh, Pennsylvania, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Jones","sequence":"additional","affiliation":[{"name":"Montefiore Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig S.","family":"Rosenfeld","sequence":"additional","affiliation":[{"name":"West Penn Hospital, Western Pennsylvania Cancer Institute, Pittsburgh, Pennsylvania, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard K.","family":"Shadduck","sequence":"additional","affiliation":[{"name":"West Penn Hospital, Western Pennsylvania Cancer Institute, Pittsburgh, Pennsylvania, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,12,23]]},"reference":[{"key":"e_1_2_1_1_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-82249-0_4"},{"key":"e_1_2_1_2_2","first-page":"953","article-title":"Myelodysplastic syndromes: natural history and features of prognostic importance","volume":"15","author":"Mufti GJ","year":"1986","journal-title":"Baillieres Clin Haematol"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0268-960X(91)90007-Y"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1982.tb02771.x"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/stem.5530080647"},{"key":"e_1_2_1_6_2","first-page":"1204","article-title":"High\u2010dose recombinant human erythropoietin for treatment of anemia in myelodysplastic syndromes and paroxysmal nocturnal hemoglobinuria: a pilot study","volume":"18","author":"Stebler C","year":"1990","journal-title":"Exp Hematol"},{"key":"e_1_2_1_7_2","first-page":"432","article-title":"Recombinant human erythropoietin in patients with myelodysplastic syndromes","volume":"5","author":"Schouten HC","year":"1991","journal-title":"Leukemia"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V78.7.1658.1658"},{"key":"e_1_2_1_9_2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1182\/blood.V79.1.29.29","article-title":"Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I\/II clinical trial","volume":"79","author":"Cazzola M","year":"1992","journal-title":"Blood"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1991.tb08594.x"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1991.tb04477.x"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1991.tb01860.x"},{"key":"e_1_2_1_13_2","first-page":"985","article-title":"Erythropoetin treatment in patients with myelodysplastic syndrome and anemia","volume":"5","author":"Kurzrock R","year":"1991","journal-title":"Leukemia"},{"key":"e_1_2_1_14_2","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1182\/blood.V79.7.1891b.1891b","article-title":"Erythropoietin therapy of myelodysplastic syndromes","volume":"79","author":"Shepherd JD","year":"1992","journal-title":"Blood"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01811466"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.3.419.419"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V49.6.855.855"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113727"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112087"},{"key":"e_1_2_1_20_2","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1182\/blood.V72.3.944.bloodjournal723944","article-title":"Synergism between erythropoietin and interleukin\u20103 in the induction of hematopoietic stem cell proliferation and erythroid burst colony formation","volume":"72","author":"Migliaccio G","year":"1988","journal-title":"Blood"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198712173172501"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.5.629"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V72.2.705.705"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V73.1.31.31"},{"key":"e_1_2_1_25_2","first-page":"335","article-title":"Effect of recombinant human granulocyte\u2010macrophage colony\u2010stimulating factor in patients with myelodysplastic syndrome with excess blasts","volume":"3","author":"Herrmann F","year":"1989","journal-title":"Leukemia"},{"key":"e_1_2_1_26_2","first-page":"273","article-title":"Comparison of intravenous versus subcutaneous recombinant human granulocyte\u2010macrophage colony\u2010stimulating factor in patients with primary myelodysplasia","volume":"19","author":"Rosenfeld CS","year":"1991","journal-title":"Exp Hematol"},{"key":"e_1_2_1_27_2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1182\/blood.V76.3.455.455","article-title":"Effects of recombinant human interleukin\u20103 in patients with myelodysplastic syndrome","volume":"76","author":"Ganser A","year":"1990","journal-title":"Blood"}],"container-title":["STEM CELLS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fstem.5530110109","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/stem.5530110109","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/stem.5530110109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T03:06:05Z","timestamp":1642561565000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stmcls\/article\/11\/1\/49-55\/6387512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1993,1]]}},"alternative-id":["10.1002\/stem.5530110109"],"URL":"https:\/\/doi.org\/10.1002\/stem.5530110109","archive":["Portico"],"relation":{},"ISSN":["1066-5099","1549-4918"],"issn-type":[{"value":"1066-5099","type":"print"},{"value":"1549-4918","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,1]]}}}